Medistro Lifesciences

We support Patients having rare diseases and special conditions by providing them solutions to their therapeutic needs.

[Medistro Lifesciences @medistro1]

I just removed a photo background in seconds and downloaded it in HD for free with Fotor's background remover. 🤩 It's so easy to use and saved me so much time! Experience fast BG removal and HD images @fotor_com now! 👉
https://t.co/4WWKT66Oqo

[Medistro Lifesciences @medistro1]

Wow! Just discovered Mailbird I love it! I can manage all my email accounts in one place with the best email client for Windows. #emailclient #productivity https://t.co/QB7IYX2emb

[Medistro Lifesciences @medistro1]

@njohncamm 𝑯𝒆 𝒅𝒐𝒆𝒔 𝒊𝒕 𝒂𝒈𝒂𝒊𝒏 & 𝒂𝒈𝒂𝒊𝒏 & 𝒂𝒈𝒂𝒊𝒏 .......🙂

[Medistro Lifesciences @medistro1]

Hey guys, check out this amazing AI photo editing tool by https://t.co/jP7Te6PikL @ai_picup. Get 5 FREE Credits Here ↓ https://t.co/Q1Fb7XEBdm

[Medistro Lifesciences @medistro1]

@AzharMalik2626 𝑯𝒊, 𝑺𝒐𝒓𝒓𝒚 𝒇𝒐𝒓 𝒕𝒉𝒆 𝒅𝒆𝒍𝒂𝒚. 𝑫𝒐 𝒚𝒐𝒖 𝒔𝒕𝒊𝒍𝒍 𝒓𝒆𝒒𝒖𝒊𝒓𝒆 𝑪𝒆𝒇𝒊𝒅𝒆𝒓𝒐𝒄𝒐𝒍?

[Medistro Lifesciences @medistro1]

We are #facilitating the procurement of #cefiderocol injection for patients in #india , thru #namedpatientprogram. Please do get in touch with us for details.

#infectionprevention @KDAHMumbai @drprabhunephro @sundar_s1955 @BasuNephro

[Medistro Lifesciences @medistro1]

P1‐6: Clinical effectiveness of cefoperazone‐sulbactam versus piperacillin‐tazobactam for the treatment of pneumonia in the elderly population https://t.co/dFSkF0jhNI

therapy with CFP-SUL is a viable alternative to PIP-TAZ with good outcomes.

[Medistro Lifesciences @medistro1]

#rarediseases #awareness is improving in #India. diseases like #mps1, #SMA etc are garnering attention.
But how can we address the #issue of #treatment access and affordability for patients with rare diseases?
@sundar_s1955 @SreejithDr @BasuNephro @renalpages @mansukhmandviya

[Medistro Lifesciences @medistro1]

Dietary #salt , How much is too much? The Silent Killer?
Probably the most underrated and ignored #issue

@renalpages @sapienshealth @sundar_s1955 @bhushan_sree @SreejithDr #Hypertension #cardiacarrest

[Sundar Sankaran @sundar_s1955]

Salt the slow poison by
Ranjan Ravichandran
of @sapienshealth
https://t.co/ZtUzczlhSU

[Medistro Lifesciences @medistro1]

clinical trials have indicated that strict control of #BloodPressure is a must to manage #Cardiovascular Diseases. Many factors may be important contributors to the gap between population #hypertension control goals and currently observed control levels
@sundar_s1955 @renalpages

[American Society of Pediatric Nephrology @ASPNeph]

Medication #Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association https://t.co/i2P8lZGek6 @HyperAHA #HTN

[Medistro Lifesciences @medistro1]

#Tubuloreticular inclusions (TRIs) can be considered as distinctive markers of #graftloss ? All the more important to study widely about the clinical significance of TRI expression.

@sundar_s1955 @SreejithDr @renalpages #kidney @arvindcanchi @ASPNeph @VijayKher8 @AmerTransplant

[Jim Moriarty @HotKidneyAction]

Carr - EM tubuloreticular inclusions in transplant biopsies are a marker of graft loss - stronger association than some more conventional graft loss risk factors #UKKW2021

[Medistro Lifesciences @medistro1]

The management of of the Finnish type -CNF is challenging. Unilateral #nephrectomy during early infancy may be an effective treatment. At this time, #kidney #transplantation seems to be the only option available for this condition
@ASPNeph @sundar_s1955 @BasuNephro @arvindcanchi

[American Society of Pediatric Nephrology @ASPNeph]

Unilateral #nephrectomy for young infants with #congenitalnephroticsyndrome of the Finnish type @ CEN #pedneph
https://t.co/pOvrtl6hFe

[Medistro Lifesciences @medistro1]

(ANCA)-associated vasculitis can present with life-threatening lung-kidney syndromes. Multi-target therapy has emerged as an effective approach. #plasmaexchange + #Rituximab + low dose #cyclophosphamide shownto achieve remission.
@ASPNeph @arvindcanchi @sundar_s1955 @renalpages

[American Society of Pediatric Nephrology @ASPNeph]

Combination treatment with #rituximab, low-dose #cyclophosphamide and #plasmaexchange for severe antineutrophil cytoplasmic antibody-associated vasculitis. @Kidney_Int #ANCA
https://t.co/Ebu2mcLKDL

[Medistro Lifesciences @medistro1]

A growing body of #evidence demonstrates that mesenchymal stromal cells are important for #kidney #glomerular #homeostasis and the glomerular response.
Can it lead to understanding of kidney disease pathogenesis?

@ASPNeph @ASNKidney @sundar_s1955 @drprabhunephro @arvindcanchi

[American Society of Pediatric Nephrology @ASPNeph]

The Mesangial cell — the glomerular stromal cell https://t.co/ta0ec7hlN1 @NatRevNeph

[Medistro Lifesciences @medistro1]

#ECMO and #CRRT , 2 critical care technologies in much in demand . The number of patients using critical care is increasing as our populations live longer thanks to advances in medical therapies
@ASPNeph @Transpl_Int @sundar_s1955 @arvindcanchi #nephrology

[American Society of Pediatric Nephrology @ASPNeph]

Extracorporeal Membrane Oxygenation and Continuous Kidney Replacement Therapy: Technology and Outcomes – A Narrative Review @ackdonline #ECMO #CRRT #openaccess
https://t.co/8aiTxsNkBU

[Medistro Lifesciences @medistro1]

These findings may have implications for #kidney physiology and disease, #laboratory diagnostics, and #anemia therapy.
@ASPNeph @Transpl_Int @drprabhunephro @sundar_s1955 #KidneyDisease #nephrology

[American Society of Pediatric Nephrology @ASPNeph]

The circadian clock regulates rhythmic #erythropoietin expression in the murine kidney. @Kidney_Int #HIF
https://t.co/OYXNZf1j6h

[Medistro Lifesciences @medistro1]

#fluid #overload is a major risk factor affecting #renal recovery post #transplant . It calls for real-time optimization of perioperative fluid management

#kidney #nephrology @sundar_s1955 @ASPNeph @arvindcanchi

[Transplant International @Transpl_Int]

#Fluid #overload in the early perioperative period post #KidneyTransplant does not promote renal recovery, but is associated with a #high #risk, contributing to DGF, cardiopulmonary and gastrointestinal complications https://t.co/0yKSlFoFec

[Medistro Lifesciences @medistro1]

Highly encouraging results. The vaccine showed a favorable #safety profile, produced a greater #immune response , and was highly effective against #Covid-19 in 12-to-15-year-old recipients.
@ASPNeph @NEJM #COVID19 @renalpages @sundar_s1955 @drprabhunephro @arvindcanchi @PMOIndia

[American Society of Pediatric Nephrology @ASPNeph]

Safety, Immunogenicity, and Efficacy of the BNT162b2 #Covid-19 #Vaccine in #Adolescents. @NEJM #openaccess

https://t.co/XQfhlt4yvi

[Medistro Lifesciences @medistro1]

𝑊ℎ𝑎𝑡 𝑖𝑠 𝑡ℎ𝑒 𝑙𝑜𝑛𝑔 𝑡𝑒𝑟𝑚 𝑜𝑢𝑡𝑐𝑜𝑚𝑒 𝑜𝑓 𝑠𝑖𝑚𝑢𝑙𝑡𝑎𝑛𝑒𝑜𝑢𝑠 #ℎ𝑒𝑎𝑟𝑡_𝑘𝑖𝑑𝑛𝑒𝑦 𝑇𝑥. 𝐼𝑠 𝑖�� 𝑤𝑜𝑟𝑡ℎ 𝑡ℎ𝑒 #𝑟𝑖𝑠𝑘? 𝐼��𝑡𝑒𝑟𝑒𝑠𝑡𝑖𝑛𝑔 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛𝑠.

#kidneytransplant @renalpages @drprabhunephro @ASPNeph

[American Society of Pediatric Nephrology @ASPNeph]

Simultaneous #heart-kidney #transplantation results in respectable long-term outcome but a high rate of early kidney #graftloss in high-risk recipients – a European single center analysis @BioMedCentral
https://t.co/lPqD84dwex

[Medistro Lifesciences @medistro1]

obstructive #sleep_apnea is major concern for #ESRD patients. often #saltintake determines the severity. The prevalence is high is directly proportional to Na+ intake and #bmi
@drprabhunephro @sundar_s1955 @SreejithDr @bhushan_sree @ASPNeph #Dialysis

[American Society of Pediatric Nephrology @ASPNeph]

Relationship between #saltintake and sleep disordered breathing in dialysis patients. #OSA @ CEN
https://t.co/ec3Sul8vPE

[Medistro Lifesciences @medistro1]

𝐹𝑟𝑜𝑚 𝑎 𝑓𝑎𝑡𝑎𝑙 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛 𝑡𝑜 𝑎 𝑡𝑟𝑒𝑎𝑡𝑎𝑏𝑙𝑒 𝐶𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛. 𝑂𝑢𝑡𝑐𝑜𝑚𝑒 𝑓𝑟𝑜𝑚 𝑎 #𝐿𝑜𝑛𝑔𝑡𝑒𝑟𝑚 𝑐𝑜ℎ𝑜𝑟𝑡 𝑡𝑟𝑖𝑎𝑙 𝑜𝑛 #𝑁𝑒𝑝ℎ𝑟𝑜𝑝𝑎𝑡ℎ𝑖𝑐_𝑐𝑦𝑠𝑡𝑖𝑛𝑜𝑠𝑖𝑠 #RareDisease .
#𝑘�#RareDisease .
#𝑘𝑖𝑑𝑛𝑒𝑦 @sund@sundar_s1955 @arvindcanchi @ASNKidney

[American Society of Pediatric Nephrology @ASPNeph]

An international cohort study spanning five decades assessed #outcomes of nephropathic #cystinosis. @Kidney_Int
https://t.co/cpn5bQY4JO